Chimeric antigen receptor T cells - Globe Thesis

Keyword [Chimeric antigen receptor T cells] Result: 41 - 60 \| Page: 3 of 4
41.	The Combination Of Drugs In Treating B-cell Malignancies: Pre-clinical Study
42.	Study Of T-cell Subsets In Peripheral Blood Of B-cell Acute Lymphoblastic Leukemia Patients And Their Effect On CD19 CAR-T Cell Therapy
43.	Construction Of A Pan-Solid Tumor-Associated Antigen Atlas And Its Application To Antibody-Drug Conjugates And Chimeric Antigen Receptor T Cells
44.	Clinical Study Of Targeting CD19 Fourth-generation Chimeric Antigen Receptor T Cells In Treating Relapsed Or Refractory B Cell Non-hodgkin Lymphoma
45.	Hematologic Toxicity And Kinetics Of Immune Function And Relevant Factors Analysis After Chimeric Antigen Receptor T Cells Therapy In Relapsed/Refractory Acute B Lymphoblastic Leukemia
46.	Construction And Identification Of PNE Peptide-regulated Universal CAR-T Cells
47.	Study On Immunotherapy Of Malignant Tumors Targeted By T Cells Modified By Mesothelin Chimeric Antigen Receptor
48.	TRAIL-R1-targeted Chimeric Antigen Receptor T Cells Exhibit Dual Antitumor Effects
49.	Construction Of Chimeric Antigen Receptor T Cells (CAR-T) Targeting HER2 And Its Killing Activity Against Tumor Cells In Vitro
50.	A Meta-analysis Of The Efficacy And Safety Of Chimeric Antigen Receptor-T Cells In The Treatment Of Relapsed/Refractory B-cell Lymphoma
51.	Functional Study Of Chimeric Antigen Receptor T Cells Co-expressing RUNX3 In Immunotherapy Of Hepatocellular Carcinoma
52.	Anti-tumor Effects Of CD276-specific Chimeric Antigen Receptor T Cells In Esophageal Squamous Cell Carcinoma
53.	Study On The Mesothelin And NKG2D Dual-Target Enhanced CAR-T In The Treatment Of Triple-Negative Breast Cancer
54.	Construction Of Chimeric Antigen Receptor T Cells With New Sequence HER2-13/66 And Their Functions In Vitro And In Vivo
55.	Optimized CD147-CART Cells Against Glioblastoma
56.	Folate Receptor-Alpha Targeted 7x19CARr-γδT Treating Triple-negative Breast Cancer:A Preclinical Study
57.	The Study Of In Vivo Cells Programming For The Treatment Of B-cell Hematological Malignancies And CAR-T-associated Hematotoxicity
58.	Experimental Study Of γδT Cells And NKG2D Chimeric Antigen Receptor T Cells Immunotherapy Against Hepatocellular Carcinoma
59.	Extracellular Vesicles Armed With Target Antigen Or Cytokines Drive Efficacy Of Chimeric Antigen Receptor-T Cells
60.	Study On Generation Of Cord Blood-derived CD19-CAR T Cells And The Anti-tumor Effects In Diffuse Large B-cell Lymphoma
<<First <Prev Next> Last>> Jump to